Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay

被引:26
作者
Smit, WM [1 ]
Rijnbeek, M [1 ]
van Bergen, CAM [1 ]
Willemze, R [1 ]
Falkenburg, JHF [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Hematol, Lab Expt Hematol, NL-2300 RC Leiden, Netherlands
关键词
cytotoxic T lymphocytes; chronic myeloid leukemia; limiting dilution assay; host-reactive;
D O I
10.1038/sj.bmt.1701135
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Donor leukocyte transfusions (DLT) have an anti-leukemic effect in most patients with a relapse of chronic myeloid leukemia (CML) after allogeneic stem cell transplantation. However, DLT are often complicated by graft-versus-host disease, Selection of donor lymphocytes with a relative specificity for leukemic cells is desirable, The generation of leukemia-reactive cytotoxic T lymphocyte (CTL) responses between HLA-identical donors and patients in bulk cultures showed major variations, and false negative results were observed, In a modification of a limiting dilution analysis (LDA) two-fold serial dilutions of HLA-identical donor mononuclear cells (MNC) were cultured in the presence of CML cells, The anti-leukemic CTL precursor frequencies in these donors varied between <1 and 9 per 10(6) MNC, KLA-restricted CD4(+) or CD8(+) lymphocytes as well as MHC non-restricted gamma delta T cells were responsible for the anti-leukemic responses, A positive correlation between cytotoxicity in the various wells after 3, 4 and 5 weeks of culture could be found, The LDA may be superior to bulk cultures in selecting stable immune responses and in separating multiple different antileukemic T cell responses in each donor-patient combination.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 33 条
[21]  
MARANINCHI D, 1987, LANCET, V2, P175
[22]  
MARIJT WAF, 1995, BONE MARROW TRANSPL, V16, P125
[23]   MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELL LINES, CAPABLE OF LYSING HUMAN HEMATOPOIETIC PROGENITOR CELLS, CAN BE GENERATED INVITRO BY STIMULATION WITH HLA-IDENTICAL BONE-MARROW CELLS [J].
MARIJT, WAF ;
VEENHOF, WFJ ;
BRAND, A ;
GOULMY, E ;
FIBBE, WE ;
WILLEMZE, R ;
VANROOD, JJ ;
FALKENBURG, JHF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :101-109
[24]  
OETTEL KR, 1994, BLOOD, V83, P3390
[25]   INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA [J].
PORTER, DL ;
ROTH, MS ;
MCGARIGLE, C ;
FERRARA, JLM ;
ANTIN, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (02) :100-106
[26]   USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION [J].
ROONEY, CM ;
SMITH, CA ;
NG, CYC ;
LOFTIN, S ;
LI, CF ;
KRANCE, RA ;
BRENNER, MK ;
HESLOP, HE .
LANCET, 1995, 345 (8941) :9-13
[27]   THE FREQUENCY OF PRETRANSPLANT DONOR CYTOTOXIC T-CELL PRECURSORS WITH ANTI-HOST SPECIFICITY PREDICTS SURVIVAL OF PATIENTS TRANSPLANTED WITH BONE-MARROW FROM DONORS OTHER THAN HLA-IDENTICAL SIBLINGS [J].
ROOSNEK, E ;
HOGENDIJK, S ;
ZAWADYNSKI, S ;
SPEISER, D ;
TIERCY, JM ;
HELG, C ;
CHAPUIS, B ;
GRATWOHL, A ;
GMUR, J ;
SEGER, R ;
JEANNET, M .
TRANSPLANTATION, 1993, 56 (03) :691-696
[28]  
SCHWARER AP, 1994, TRANSPLANTATION, V58, P1198, DOI 10.1097/00007890-199412150-00011
[29]   LIMITING DILUTION ANALYSIS OF HUMAN T-CELLS - A USEFUL CLINICAL TOOL [J].
SHARROCK, CEM ;
KAMINSKI, E ;
MAN, S .
IMMUNOLOGY TODAY, 1990, 11 (08) :281-286
[30]   LIMITING DILUTION ASSAYS - EXPERIMENTAL-DESIGN AND STATISTICAL-ANALYSIS [J].
STRIJBOSCH, LWG ;
BUURMAN, WA ;
DOES, RJMM ;
ZINKEN, PH ;
GROENEWEGEN, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 97 (01) :133-140